0

Tyr-Ile-Gly-Ser-Arg

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP110590642
CAS110590-64-2
Structure
MDL NumberMFCD00076472
Molecular Weight594.66
InChI KeyMWOGMBZGFFZBMK-LJZWMIMPSA-N
Description≥97% (HPLC)
SolubilityH2O: soluble 1 mg/mL, clear, colorless
Assay≥97% (HPLC)
Size1MG, 5MG
Storage Conditions−20°C
1

Antimetastatic Effects of Synthetic Polypeptides Containing Repeated Structures of the Cell Adhesive Arg-Gly-Asp (RGD) and Tyr-Ile-Gly-Ser-Arg (YIGSR) Sequences

I Saiki, J Murata, J Iida, T Sakurai, N Nishi, K Matsuno, I Azuma

Br J Cancer. 1989 Nov;60(5):722-8.

PMID: 2803948

1

Covalent Surface Immobilization of Arg-Gly-Asp- And Tyr-Ile-Gly-Ser-Arg-containing Peptides to Obtain Well-Defined Cell-Adhesive Substrates

S P Massia, J A Hubbell

Anal Biochem. 1990 Jun;187(2):292-301.

PMID: 2382830

1

Covalently Immobilized Laminin Peptide Tyr-Ile-Gly-Ser-Arg (YIGSR) Supports Cell Spreading and Co-Localization of the 67-kilodalton Laminin Receptor With Alpha-Actinin and Vinculin

S P Massia, S S Rao, J A Hubbell

J Biol Chem. 1993 Apr 15;268(11):8053-9.

PMID: 8463322

1

Multimeric Forms of Tyr-Ile-Gly-Ser-Arg (YIGSR) Peptide Enhance the Inhibition of Tumor Growth and Metastasis

M Nomizu, K Yamamura, H K Kleinman, Y Yamada

Cancer Res. 1993 Aug 1;53(15):3459-61.

PMID: 8339246

1

The Laminin-Derived Peptide YIGSR (Tyr-Ile-Gly-Ser-Arg) Inhibits Human pre-B Leukaemic Cell Growth and Dissemination to Organs in SCID Mice

N Yoshida, E Ishii, M Nomizu, Y Yamada, S Mohri, N Kinukawa, A Matsuzaki, K Oshima, T Hara, S Miyazaki

Br J Cancer. 1999 Aug;80(12):1898-904.

PMID: 10471037

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode